ZNF469 participates in extracellular matrix regulation. It downregulates several collagen and adhesion molecules. While it has no confirmed clinical role in TAAD, it may function as a modifier gene. It is known for causing brittle cornea syndrome and could influence vascular fragility due to its ECM effect. Here, ZNF469 is linked to brittle cornea syndrome.